|
|
SEVENTH INTERNATIONAL PHARMACEUTICAL COMPLIANCE CONGRESS
May 21 - 23, 2013
|
ONSITE
|
ONLINE
|
Meliá Castilla Hotel
Madrid, Spain |
In your own office or home live via the Internet with 24/7 access for 6 months
|
|
|
GABOR DANIELFY MEMORIAL
KEYNOTE ADDRESS
|
Elvira Sanz Urgoiti
President, Pfizer Spain, President, Farmaindustria, Madrid, Spain
|
|
|
ETHICS
KEYNOTE ADDRESS
|
Marc Le Menestrel, PhD
Visiting Professor of Ethics, INSEAD, Associate Professor, University
Pompeu Fabra (Barcelona), Barcelona, Spain
|
|
|
TRANSFORMING THE COMPLIANCE PROFESSION KEYNOTE ADDRESS
|
Arthur Muratyan, Esq.
Secretary General of Ethics, International Society of HealthCare Ethics and Compliance Professionals; Former Vice President-Head of Legal Corporate, and Global Compliance Officer, Sanofi, Paris, France
|
|
|
TRANSPARENCY
INT'L KEYNOTE ADDRESS
|
Huguette Labelle, CC, PhD, LLD
Chair, Transparency International, Companion of the Order of Canada, Berlin, Germany
|
|
|
OTHER KEYNOTE SPEAKERS
|
Reinhard Angelmar, PhD
Salmon and Rameau Fellow of Healthcare, Management Professor of Marketing, INSEAD, Appointments, Sloan School (MIT), Stockholm School of Economics, ESSEC Business School, and Universite Paris Dauphine, Fontainebleau, France |
Carl H. Coleman, JD
Professor of Law and Director of Global Initiatives, Center for Health & Pharmaceutical Law & Policy and Gibbons, Institute of Law, Science & Technology, Seton Hall University School of Law, Former Bioethics and Law Adviser, World Health Organization (WHO), Newark, NJ |
Jose F. Zamarriego Izquierdo
Director Unidad de Supervision Deontologica, FARMAINDUSTRIA, Madrid, Spain
|
Tamara Music
Manager, Influenza Vaccines & Code Compliance, IFPMA, Geneva, Switzerland |
Marie-Claire Pickaert
Deputy Director General, European Federation of Pharmaceutical Industries and Associations (EFPIA), Brussels, Belgium |
Heather Simmonds
Director and Chair, Code of Practice Panel, Prescription Medicines Code of Practice Authority, London, UK
|
|
|
|
A SPECIAL COMPLIMENTARY, INVITATION-ONLY
SPANISH COMPLIANCE ROUNDTABLE
On Tuesday, May 21, 2013 immediately prior to the Congress
Sponsored by FARMAINDUSTRIA FEATURING
|
Arancha Burgos
Spanish Code Surveillance Unit, FARMAINDUSTRIA, Madrid, Spain |
Santiago Páramo
Spanish Code Surveillance Unit, FARMAINDUSTRIA, Madrid, Spain |
Olga Sanz
Spanish Code Surveillance Unit, FARMAINDUSTRIA, Madrid, Spain
|
Julián Zabala
Head of Communications, FARMAINDUSTRIA, Madrid, Spain |
Jose F. Zamarriego Izquierdo
Director Unidad de Supervision Deontologica, FARMAINDUSTRIA, Madrid, Spain (Moderator)
|
|
|
|
|
|
PLENARY SESSIONS
|
- Business Ethics for Pharma and Device Companies
- Roundtable on Integrating Ethics Theory into Ethics Practice
- Global Anticorruption Roundtable
- EU Transparency Roundtable
- Compliance Issues and Congresses
- The Role of the International Society of Healthcare Ethics and Compliance Professionals (ethics)
- Compliance as a Profession: Common Body of Knowledge, Training, Professional Ethics and Professional Certification
|
|
INTERNATIONAL PHARMA CONGRESS IS
|
|
|
|
|
AND MINI SUMMITS
|
- Mini Summit I: Basic Compliance Training
- Mini Summit II: Global Auditing and Monitoring Best Practices I
- Mini Summit III: Annual MEA Compliance Roundtable
- Mini Summit IV: Social Media, Apps and eDigital Space
- Mini Summit V: Crucial Compliance Resources And Non-Material Support For Compliance Officers
- Mini Summit VI: INSEAD Case Study
- Mini Summit VII: Annual CEE Compliance Update
- Mini Summit VIII: Advanced Issues In Global Transparency
- Mini Summit IX: Global Compliance Issues And Initiatives In The Medical Device Sector
- Mini Summit X: Global Anti-Bribery Compliance
- Mini Summit XI: Global Auditing and Monitoring Best Practices II
- Mini Summit XII: Global Compliance Issues Update
- Mini Summit XIII: Public Procurement and Pharma Pricing Update
- Mini Summit XIV: Global Compliance Codes Update
- Mini Summit XV: Pre- And Post-Transaction Due Diligence For Compliance
- Mini Summit XVI: Making Use Of Case Studies As An Educational Tool
- Mini Summit XVII: Achilles Heel in Managing Global Corruption and Preventing Your Initiative's Downfall
|
|
|
|
ETHICS UPDATE
|
Isaure Kergall-Gayet, Esq.
Vice President, Chief Ethics and Compliance Officer, Ipsen; Former Director, Ethics & Compliance Officer, Member of the Executive Committee, Lilly France, Paris, France |
Dan Ostergaard
Founder and Chief Executive Officer, Integrity by Design, Former Head of Corporate Integrity and Compliance, Novartis AG, Basel, Switzerland |
Guido Palazzo, PhD
Professor of Business Ethics, University of Lausanne, Visiting Fellow, Universities of Nottingham and Oxford, Member, Editorial Boards, Business Ethics Quarterly, and Business & Society, Lausanne, Switzerland
|
Michael Petty, Esq.
Partner, FDA & Life Sciences Group, King & Spalding, Former Vice President of Development and Regulatory Law, Amgen Inc., Former Associate Chief Counsel for Enforcement and Counselor, Division of Import Operations and Policy, US Food and Drug Administration, Washington, DC, USA |
Lori Queisser
Principal, Advisory Services, KPMG LLP, Former Senior Vice President, Global Compliance and Business Practices, Schering-Plough Corporation, Former Member, PCF Executive Committee, Indianapolis, IN, USA
|
Aditi Taylor
Senior Manager, Advisory Services, Deloitte & Touche LLP, Boston, MA |
Paul B. Woods, BPharm, MA, MRPharmS
Independent Consultant; Former Global Compliance Policy Director, AstraZeneca, Macclesfield, Cheshire, UK
|
|
|
|
|
GLOBAL ANTICORRUPTION UPDATE
|
Peter Dieners, Esq.
Partner, Clifford Chance, Düsseldorf, Germany |
Chris Georgiou
Deloitte, Madrid, Spain |
Gary F. Giampetruzzi, Esq.
Vice President and Assistant General Counsel, Head of Government Investigations, Pfizer Inc., New York, NY, USA
|
Edward F. Hanover, Esq.
General Counsel, Novo Nordisk Region International Operations A/S, Zurich, Switzerland |
Marc L. Miller
Partner, KPMG LLP, New York, NY, USA |
Lewis Morris, Esq.
Senior Counsel, Adelman, Sheff and Smith LLC, Former Chief Counsel to the Inspector General, Office of Inspector General, US Department of Health and Human Services, Annapolis, MD, USA
|
Vivian Robinson, Esq.
Partner, McGuireWoods; Former General Counsel of the UK Serious Fraud Office; Former Head, QEB Hollis Whiteman Chambers; Recorder of the Crown Court and Treasurer of Inner Temple, London, UK |
Joseph B. Tompkins, Jr.
Partner, Sidley Austin LLP, Former Deputy Chief of the Fraud Section, Criminal Division, United States Department of Justice, Washington, DC, USA
|
Juan Valderas
Partner, Forensic & Dispute Services, Deloitte Financial Advisory Services, LLP, Madrid, Spain |
SanDee Priser, MAS, JD
Principal, Ernst & Young LLP, New York, NY (Moderator)
|
|
|
|
|
GLOBAL TRANSPARENCY UPDATE
|
Dr. Michael Bartke
Director Compliance Management, DAIICHI SANKYO EUROPE GmbH, Co-chair, EFPIA Compliance Workgroup, Munich, Germany |
Andy Bender, MS, MBA
President, Polaris, New York, NY, USA |
Carsten Blaesberg
Chief Consultant, Lif Denmark, The Danish Association of the Pharmaceutical Industry, Copenhagen, Denmark
|
Julie Bonhomme, Esq.
Legal Manager, Legal and Compliance Department, LEEM, Paris, France |
William E. Buzzeo, MS
Vice President and General Manager, Global Compliance Solutions, Cegedim Relationship Management, Richmond, VA, USA |
Johan Holm
Senior Manager, Polaris, Amsterdam, The Netherlands
|
Daniel A. Kracov, Esq.
Partner and Head, FDA and Healthcare Practice, Arnold & Porter, Washington, DC, USA |
Evelyne Lemaire
Director, Global Pharmaceutical and Life Sciences, PwC LLP, Zurich, Switzerland |
Andrew Parks
Director, KPMG, McLean, VA, USA
|
Heather Simmonds
Director, Prescription Medicines Code of Practice Authority, London, UK |
Matthijs M. van Blokland, Esq.
General Counsel, Prosensa, General Counsel and Senior Policy Advisor Legal Affairs, Association Innovative Medicines, Nefarma, Board Member, Stichting CGRz, Amsterdam, The Netherlands
|
|
|
|
|
GLOBAL COMPLIANCE ISSUES AND CODES UPDATES
|
Bulent Becan
Managing Partner, Atuva Management Consultancy, and Trade Ltd.; Consultant in Ethics Issues, Turkish Research Based, Pharmaceutical Companies Association (AIFD), Istanbul, Turkey |
Joe Henein
President and Chief Executive Officer, NewBridge Pharmaceuticals, Former Regional Managing Director, Middle East, and North Africa, Wyeth Pharmaceuticals, Dubai, United Arab Emirates
|
Juan Francisco Millán Soberanes, MD
Secretary and Executive Director, CETIFARMA, Mexico City, Mexico |
Keith M. Korenchuk, JD, MPH
Partner, Arnold & Porter LLP, Washington, DC, USA
|
|
|
|
|
GLOBAL COMPLIANCE ISSUES IN THE MEDICAL DEVICE SECTOR
|
Suzanne Durdevic, DEA, LLM
Senior Director, General Counsel, EMEA, Boston Scientific International; Chair, Legal Affairs Group, EUCOMED, Paris, France |
Anthony McQuillan, Esq.
Vice President Legal and Compliance EMEA, Medtronic; Chair, EUCOMED Code Committee, Tolochenaz, Switzerland |
Elisabethann Wright, Esq.
Partner, Hogan Lovells; Former Senior Legal Officer and Hearing Officer, EFTA Surveillance Authority, Brussels, Belgium
|
Brian Riewerts
Partner, Global Pharmaceuticals and Life Sciences, PwC LLP Baltimore, MD, USA (Co-moderator) |
Roeland Van Aelst
Vice President EMEA & Canada, Health Care Compliance and Privacy, Johnson & Johnson; Board Member and Co-chair, Strategic Committee, International Society of Healthcare Ethics and Compliance Professionals (ethics), Brussels, Belgium (Co-moderator)
|
|
|
|
|
CONGRESSES AND REALITIES: CROSS-BORDER CONFLUENCE, TERRITORIAL ISSUES VS. GLOBAL ACTIVITIES, MIXING IFPMA/EFPIA CODES WITH CONGRESS AND SOCIETY RULES
|
Marie-Claire Pickaert
Deputy Director General, European Federation of Pharmaceutical Industries and Associations (EFPIA), Brussels, Belgium |
Jeff Rosenbaum
Vice President, Chief Compliance Officer, Vertex Pharmaceuticals, Former Executive Director, Global Head of Ethics & Compliance Novartis Oncology, Boston, MA |
Debra C. Forster, Esq.
Global Compliance Officer, Novartis Pharma AG, Basel, Switzerland
|
Christian-Claus Roth
Head of Congresses and Conventions, Novartis Pharma; Co-President, International Pharmaceutical Congress Advisory Association (IPCAA), Basel, Switzerland |
Ann Beasley Bacon
Vice President Corporate Compliance, International, Biogen Idec International, GmbH (as of March 1); Former Global Compliance Officer, Novartis Pharma AG; Board Member and Co-chair, Strategic Committee, International Society of Healthcare, Ethics and Compliance Professionals (ethics), Zug, Switzerland (Moderator)
|
|
|
|
|
BASIC COMPLIANCE TRAINING
|
Sue Egan
Director and Principal Consultant, Sue Egan Associates, Editor, Life Science Compliance, Former Vice President Compliance, AstraZeneca, Great Missenden, Buckinghamshire, UK
|
|
|
|
CRUCIAL COMPLIANCE RESOURCES
|
Tomasz Kruk, LL M, MBA
Director Global Ethics and Compliance, Actavis, Zug, Switzerland
|
|
|
EMERGING COMPLIANCE ISSUES: SOCIAL MEDIA, APPS AND eDIGITAL SPACE
|
Bulent Becan
Managing Partner, Atuva Management Consultancy and Trade Ltd., Consultant in Ethics Issues, Turkish Research Based Pharmaceutical Companies Association (AIFD), Istanbul, Turkey |
Noelia de Miguel, PhD, Esq.
Senior Associate and Head of Life, Sciences Regulatory Spain, Hogan Lovells International LLP, Madrid, Spain
|
Denise Silber
President, Basil Strategies Digital Consultancy and Organizers, Doctors 2.0 & You Conference, Paris, France |
Philippe Cloarec
European Ethics and Compliance Associate - CCEP-I, Eli Lilly and Company, Geneva, Switzerland (Moderator)
|
|
|
|
|
BEST PRACTICES IN GLOBAL AUDITING AND COMPLIANCE MANAGEMENT SYSTEMS
|
Yogesh Bahl, MBA
Partner, National Practice Leader - Life Sciences, Deloitte Financial Advisory Services LLP, New York, NY, USA |
Andy Bender, MS, MBA
President, Polarism New York, NY, USA
|
|
|
|
|
THIRD PARTY AUDITS
|
George Fife
Director, EMEA Compliance and Ethics, Bristol-Myers, Squibb, Paris, France |
Michele Tagliaferri, Esq.
Counsel, Sidley Austin LLP, Brussels, Belgium |
Kip Ebel
Principal - Life Sciences, Assurance, Ernst & Young, Iselin, NJ (Moderator)
|
|
|
|
|
PRE- AND POST-TRANSACTION DUE DILIGENCE
|
Brian E. Kowalski, Esq.
Associate, Latham & Watkins, Washington, DC, USA |
Greg Crouse
Principal, Ernst & Young LLP, Moscow, Russia (Moderator)
|
|
|
|
|
COMPLIANCE CASE STUDIES
|
Nancy A. Grygiel, LD, LLM
Senior Director, International Business Compliance, Allergan, Irvine, CA, USA |
Jonathon Kellerman
Principal, Pharmaceutical and Life, Sciences Advisory Services, PwC LLP, Florham Park, NJ, USA (Co-moderator) |
Gerard Geneen
Vice President, Compliance Officer, Pharma Europe GlaxoSmithKline, Brentford, Middlesex, United Kingdom (Co-moderator)
|
|
|
|
|
CENTRAL AND EASTERN (CEE) UPDATE
|
Oleksiy Bezhevets, JD, MBA
Partner, ARCA Law Firm; Partner, Legal Alliance Company, Ukraine |
Paul J. Melling, Esq.
Founding Partner, Baker & McKenzie - CIS, Limited, Moscow, Russia |
Mariusz Witalis
Partner, Fraud Investigation and Dispute Services, Ernst & Young LLP, Warsaw, Poland (Moderator)
|
|
|
|
|
MIDDLE EAST AFRICA (MEA) UPDATE
|
Hulya Baran
Director, Ethics and Compliance TMEA - CIS, Eli Lilly and Company, Istanbul, Turkey |
Meltem Ozker Gunduz
Legal Affairs and Compliance Director, Business Area Near East, Novo Nordisk, Istanbul, Turkey |
Liz MacGillivray
Compliance Director, Anti-Bribery, Country Support & Monitoring, Group Integrity and Compliance, Novartis International AG, Basil, Switzerland
|
Laura Nassar
Regional Pharma HCC Officer Emerging Markets, Johnson & Johnson, Beirut, Lebanon |
Joe Henein
President and Chief Executive Officer, NewBridge Pharmaceuticals, Former Regional Managing Director, Middle East, and North Africa, Wyeth Pharmaceuticals, Dubai, United Arab Emirates (Moderator)
|
|
|
|
|
COMPLIANCE ISSUES FOR SMALL-MID SIZE PHARMA AND BIOTECH COMPANIES
|
Maurits J.F. Lugard, MA, JD, LLM
Partner, Sidley Austin LLP, Former Member of the European Commission's Legal Service, Brussels, Belgium |
John Patrick Oroho, Esq.
Executive Vice President and Chief Strategy Officer, Porzio Life Sciences, LLC; Principal, Porzio, Bromberg & Newman PC, Morristown, NJ, USA
|
|
|
|
|
EFFECTIVE MANAGEMENT OF CROSS-BORDER EXPERT ENGAGEMENTS
|
Wayne Baker
Senior Vice President and Chief Sales Officer, AHM, New Providence, NJ, USA |
Iain Holloway-McLean
Medical Operations Director, GlaxoSmithKline, Brentford, UK
|
|
|
|
|
SPECIAL SPANISH STAKEHOLDERS ROUNDTABLE
|
Alfonso Aguaron
International Relations, GEPAC, Madrid, Spain |
Dr. Antonio Cachá Acosta
Deputy Director General for Evaluation and Control, Healthcare Ministry of the Regional Government, Community of Madrid, Madrid, Spain
|
Neus Rams, PharmD
Deputy Director of Pharmacy and Medical Devices, Ministry of Health, Government of Catalonia, Barcelona, Spain |
Dr. Miguel Ángel Caracuel Ruiz
Vice-President, Spanish Federation of Scientific Medical Associations, Científico Médicas Españolas (FACME), Madrid, Spain
|
|
|
|
|
|
|
|
|
SPONSORED BY:
|
|
|
|
CO-SPONSORED BY:
|
|
|
|
MEDIA PARTNERS
|
|
|
CONGRESS CO CHAIRS
|
Ann Beasley Bacon
Vice President Corporate Compliance, International, Biogen Idec International, GmbH (as of March 1); Former Global Compliance Officer, Novartis Pharma AG; Board Member and Co-chair, Strategic Committee, International Society of Healthcare, Ethics and Compliance Professionals (ethics), Zug, Switzerland
|
Dominique Laymand, Esq.
Vice President Compliance & Ethics EMEA, (Europe, Middle-East, Africa, Russia and Turkey), Bristol-Myers Squibb, President, International Society of Healthcare, Ethics and Compliance Professionals (ethics), Paris, France
|
Roeland Van Aelst
Vice President EMEA & Canada, Johnson & Johnson, Board Member and Co-chair, Strategic Committee, International Society of Healthcare, Ethics and Compliance Professionals (ethics), Brussels, Belgium
|
|
|
|
GRANTORS:
|
|
DIAMOND
|
|
|
PLATINUM
|
|
|
GOLD
|
|
|
SILVER
|
|
|
BRONZE
|
|
|
INTERNATIONAL PHARMA CONGRESS PLANNING COMMITTEE
|
Ann Beasley Bacon
Vice President Corporate Compliance, International, Biogen Idec International, GmbH (as of March 1); Zug, Switzerland (Co chair)
Dominique Laymand, Esq.
Vice President Compliance & Ethics EMEA (Europe, Middle-East, Africa, Russia and Turkey), Bristol-Myers Squibb, Paris, France (Co chair)
Michael J. Morgan
Ethics and Compliance Officer, Australia, Canada and Europe, Eli Lilly and Company, Windlesham, Surrey, United Kingdom (Co chair)
Roeland Van Aelst
Vice President EMEA & Canada, J&J Office Health Care Compliance & Privacy, Johnson&Johnson, Brussels, Belgium (Co chair)
Ted Acosta, Esq.
Principal, Ernst & Young LLP, Former Senior Counsel, Office of Inspector General, US Department of Health and Human Services, New York, NY, USA and Paris, France
Ronny Arijs
Vice President Global Sustainability & Chief Compliance Officer, Grunenthal, Former Senior Compliance Manager GE Healthcare, Brussels, Belgium
Yogesh Bahl, MBA
Partner, National Practice Leader - Life Sciences, Deloitte Financial Advisory Services LLP, New York, NY, USA
Wayne Baker
Senior Vice President & Chief Sales Officer, Advanced Health Media LLC, New Providence, NJ, USA
Bulent Becan
Managing Partner, Atuva Management Consultancy and Trade Ltd., Consultant in Ethics Issues, Turkish Research Based Pharmaceutical Companies Association (AIFD), Istanbul, Turkey
Andy Bender, MS, MBA
President, Polaris, New York, NY, USA
John T. Bentivoglio, Esq.
Partner, Skadden Arps LLP, Former Special Counsel for Healthcare Fraud, and Chief Privacy Officer, US Department of Justice, Washington, DC, USA
Hugh C. Bigwood
Ethics and Compliance Officer, International Operations, Abbott Laboratories, Maidenhead, Berkshire, United Kingdom
William E. Buzzeo, MS
Vice President and General Manager, Global Compliance Solutions, Cegedim Relationship Management, Richmond, VA, USA
Antonio Cavallaro
Compliance & Internal Auditing Senior Manager, Takeda Italia, Rome, Italy
Peter Dieners, Esq.
Partner, Clifford Chance, Düsseldorf, Germany
Pierre E. Dupourque
Regional Compliance Director, Corporate Compliance, International Investigations and Programs, Pfizer Inc., Mannheim, Germany
Sue Egan
Director and Principal Consultant, Sue Egan Associates, Editor, Life Science Compliance, Former Vice President Compliance, AstraZeneca, Great Missenden, Buckinghamshire, UK
Annette Schutt Fiig
Director, Risk Office, Novo Nordisk, Copenhagen, Denmark
Gerard Geneen
Vice President, Compliance Officer, Pharma Europe, GlaxoSmithKline, Brentford, Middlesex, United Kingdom
Nancy A. Grygiel, JD, LLM
Senior Director, Corporate Compliance, Business Compliance, International, Allergan, Irvine, CA, USA
Jose F. Zamarriego Izquierdo
Director Unidad de Supervision Deontologica, FARMAINDUSTRIA, Madrid, Spain
Jonathon Kellerman
Principal, Pharmaceutical and Life Sciences Advisory Services, PwC LLP, Florham Park, NJ, USA
Keith M. Korenchuk, JD, MPH
Partner, Arnold & Porter LLP, Washington, DC, USA
Tomasz Kruk
Director Global Ethics & Compliance, Actavis, Zug, Switzerland
Paul J. Melling, Esq.
Founding Partner, Baker & McKenzie - CIS, Limited, Moscow, Russia
Marc L. Miller
Partner, KPMG LLP, New York, NY, USA
Maxine Nogard
Senior Director, Global Corporate Compliance, Biogen Idec Inc., Weston, MA, USA
John Patrick Oroho, Esq.
Executive Vice President and Chief Strategy Officer, Porzio Life Sciences, LLC; Principal, Porzio, Bromberg & Newman PC, Morristown, NJ, USA
Eric Siegel
Executive Vice President & General Counsel, Incyte Corporation, Wilmington, DE, USA
Joseph B. Tompkins, Jr.
Partner, Sidley Austin LLP, Former Deputy Chief of the Fraud Section, Criminal Division of the United States Department of Justice, Washington, DC, USA
Paul B. Woods, BPharm, MA, MRPharmS
Independent Consultant, Former Global Compliance Policy Director, AstraZeneca, Macclesfield, Cheshire, UK
Elisabethann Wright, Esq.
Partner, Hogan Lovells, Former, Senior Legal Officer and Hearing Officer, EFTA Surveillance Authority, Brussels, Belgium
|
|
|
INTERNATIONAL PHARMA CONGRESSES
|
2007 - Brussels, Belgium
2008 - Paris, France
2009 - Rome, Italy
2010 - Berlin, Germany
2011 - Istanbul, Turkey
2011 - Singapore
2012 - Budapest, Hungary
2012 - Shanghai, China
2012 - São Paulo, Brazil
2013 - Madrid, Spain
2013 - Kuala Lumpur, Malaysia
|
|
|
FEATURING VIDEO PRESENTATIONS BY PHARMA LEADERS:
|
|
2012 Second Asia Pacific Pharma Congress Keynote Address by
|
Mark Mallon, MBA
Regional Vice President Asia Pacific and President China, AstraZeneca, Former Executive Vice-President and Chief Operating Officer, AstraZeneca KK (Japan), Shanghai, China
|
|
2012 Sixth International Pharma Congress Keynote Address by
|
Christopher A. Viehbacher
Chief Executive Officer, Sanofi, Chairman, Genzyme, Paris, France
|
|
2011 Twelfth Pharmaceutical Regulatory Compliance Congress and Best Practices Forum by
|
John C. Lechleiter, PhD
Chairman, President and Chief Executive Officer, Eli Lilly and Company, Chairman-elect, PhRMA, Indianapolis, IN
|
|
2011 Fifth International Pharma Congress Keynote Address by
|
David Brennan
Former Chief Executive Officer, AstraZeneca, President, IFPMA, Past Chairman, PhRMA, London, UK
|
|
FOLLOW INTERNATIONAL PHARMA CONGRESS ON
|
|
|
|
|
|
|
|
